July 10 (Reuters) - Glenmark Pharmaceuticals Ltd GLEN.NS:
ICHNOS GLENMARK INNOVATION (IGI) AND ABBVIE ANNOUNCE EXCLUSIVE GLOBAL LICENSING AGREEMENT
LICENSING AGREEMENT FOR ISB 2001
IGI WILL RECEIVE AN UPFRONT PAYMENT OF $700 MILLION, ELIGIBLE TO RECEIVE UP TO $1.225 BILLION
Source text: ID:nBSE3Lp8jW
Further company coverage: GLEN.NS
((Reuters.Briefs@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。